The DOI matches its Crossref record.
International Prices And Availability Of Pharmaceuticals In 2005
Abstract
This paper compares pharmaceutical spending, availability, use, and prices in twelve countries in 2005. Drug spending per capita was higher in the United States than in other countries. The United States had relatively high use of new drugs and high-strength formulations; other countries used more of older drugs and weaker formulations. Thus, whether U.S. overall volume of use is lower or higher depends on the measure of volume and type of product. Comprehensive price indexes show foreign prices to be 20-40 percent lower than U.S. manufacturer prices, but only 10-30 percent lower than U.S. public prices. Generics are cheaper in the United States than in other countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The economic impact of assisted reproductive technology: a review of selected developed countries
Chambers, G. M., Sullivan, E. A., Ishihara, O., Chapman, M. G., & Adamson, G. D. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.029 · Cited by 438
The Perfect Storm of Overutilization
Emanuel, E. J. (2008) · JAMA · doi:10.1001/jama.299.23.2789 · Cited by 390
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending
WOUTERS, O. J., KANAVOS, P. G., & McKEE, M. (2017) · The Milbank Quarterly · doi:10.1111/1468-0009.12279 · Cited by 287
(2016) · doi:10.1596/25062 · Cited by 14
Metadata
- Authors
- Danzon, P. M., & Furukawa, M. F.
- Venue
- Health Affairs
- Publisher
- Health Affairs Publishing, LLC
- Published
- 2008-01
- Volume
- 27
- Issue
- 1
- Pages
- 221-233
- ISSN
- 0278-2715 (ISSN-L)
- 1544-5208
- OpenAlex
- W2063813034
- Cited by
- 170
- References
- 0
- FWCI
- 39.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: International Prices And Availability Of Pharmaceuticals In 2005. https://app.cochat.ai/papers/10.1377/hlthaff.27.1.221
- The paper
- Danzon, P. M., & Furukawa, M. F. (2008). International Prices And Availability Of Pharmaceuticals In 2005. Health Affairs. https://doi.org/10.1377/hlthaff.27.1.221
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.